{"id":"https://openalex.org/W1593774567","doi":"https://doi.org/10.1111/pcn.12150","title":"Pregnenolone treatment reduces severity of negative symptoms in recent\u2010onset schizophrenia: An 8\u2010week, double\u2010blind, randomized add\u2010on two\u2010center trial","display_name":"Pregnenolone treatment reduces severity of negative symptoms in recent\u2010onset schizophrenia: An 8\u2010week, double\u2010blind, randomized add\u2010on two\u2010center trial","alternate_titles":[],"publication_year":2014,"publication_date":"2014-02-18","ids":{"openalex":"https://openalex.org/W1593774567","doi":"https://doi.org/10.1111/pcn.12150","mag":"1593774567","pmid":"https://pubmed.ncbi.nlm.nih.gov/24548129"},"language":"en","primary_location":{"id":"doi:10.1111/pcn.12150","doi":"https://doi.org/10.1111/pcn.12150","is_oa":false,"landing_page_url":"https://doi.org/10.1111/pcn.12150","pdf_url":null,"source":{"id":"https://openalex.org/S111042112","display_name":"Psychiatry and Clinical Neurosciences","issn_l":"1323-1316","issn":["1323-1316","1440-1819"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Neurosciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1593774567"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113536965","display_name":"Michael S. Ritsner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210144751","display_name":"Sha'ar Menashe Mental Health Center","ror":"https://ror.org/054gg1x85","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210144751"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael S. Ritsner","raw_affiliation_strings":["Sha'ar Menashe Mental Health Center, Hadera, Israel","The Rappaport Faculty of Medicine, Technion, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sha'ar Menashe Mental Health Center, Hadera, Israel","institution_ids":["https://openalex.org/I4210144751"]},{"raw_affiliation_string":"The Rappaport Faculty of Medicine, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030703805","display_name":"Hisham Bawakny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hisham Bawakny","raw_affiliation_strings":["The Rappaport Faculty of Medicine, Technion, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Rappaport Faculty of Medicine, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013146286","display_name":"Anatoly Kreinin","orcid":"https://orcid.org/0000-0002-1382-5832","observed_orcids":["https://orcid.org/0000-0002-1382-5832"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]},{"id":"https://openalex.org/I4210152234","display_name":"Tirat Carmel Mental Health Center","ror":"https://ror.org/04jjkfw48","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210152234"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anatoly Kreinin","raw_affiliation_strings":["The Rappaport Faculty of Medicine, Technion, Haifa, Israel","Tirat Carmel Mental Health Center, Tirat Carmel, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Rappaport Faculty of Medicine, Technion, Haifa, Israel","institution_ids":["https://openalex.org/I174306211"]},{"raw_affiliation_string":"Tirat Carmel Mental Health Center, Tirat Carmel, Israel","institution_ids":["https://openalex.org/I4210152234"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5113536965"],"corresponding_institution_ids":["https://openalex.org/I174306211","https://openalex.org/I4210144751"],"apc_list":{"value":3240,"currency":"USD","value_usd":3240},"apc_paid":null,"fwci":3.8957,"has_fulltext":false,"cited_by_count":62,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93488406,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"68","issue":"6","first_page":"432","last_page":"440"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pregnenolone","display_name":"pregnenolone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.6489999890327454},{"id":"https://openalex.org/keywords/recent-onset-schizophrenia","display_name":"recent-onset schizophrenia","score":0.9300000071525574},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neurosteroids","display_name":"neurosteroids","score":0.8529999852180481},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antipsychotic-non-response","display_name":"antipsychotic non-response","score":0.7170000076293945},{"id":"https://openalex.org/keywords/mood-stabilizers","display_name":"mood stabilizers","score":0.828000009059906},{"id":"https://openalex.org/keywords/blunted-affect","display_name":"blunted affect","score":0.9620000123977661},{"id":"https://openalex.org/keywords/avolition","display_name":"avolition","score":0.906000018119812},{"id":"https://openalex.org/keywords/anhedonia","display_name":"anhedonia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C2780193516","wikidata":"https://www.wikidata.org/wiki/Q412158","display_name":"Pregnenolone","level":4,"score":0.7858067750930786},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5517605543136597},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5391156673431396},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5060777068138123},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4977128803730011},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48321664333343506},{"id":"https://openalex.org/C2778941446","wikidata":"https://www.wikidata.org/wiki/Q545365","display_name":"Anhedonia","level":3,"score":0.4782596826553345},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4680210053920746},{"id":"https://openalex.org/C2780442968","wikidata":"https://www.wikidata.org/wiki/Q7429722","display_name":"Scale for the Assessment of Negative Symptoms","level":4,"score":0.4341791868209839},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4281628727912903},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.41839149594306946},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.29737192392349243},{"id":"https://openalex.org/C3019023267","wikidata":"https://www.wikidata.org/wiki/Q1441305","display_name":"Negative symptom","level":3,"score":0.21349754929542542},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2780902042","wikidata":"https://www.wikidata.org/wiki/Q177911","display_name":"Steroid","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011284","descriptor_name":"Pregnenolone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011284","descriptor_name":"Pregnenolone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D039721","descriptor_name":"Diagnostic and Statistical Manual of Mental Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/pcn.12150","doi":"https://doi.org/10.1111/pcn.12150","is_oa":false,"landing_page_url":"https://doi.org/10.1111/pcn.12150","pdf_url":null,"source":{"id":"https://openalex.org/S111042112","display_name":"Psychiatry and Clinical Neurosciences","issn_l":"1323-1316","issn":["1323-1316","1440-1819"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Neurosciences","raw_type":"journal-article"},{"id":"pmid:24548129","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24548129","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and clinical neurosciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W44771556","https://openalex.org/W166500168","https://openalex.org/W1271082088","https://openalex.org/W1564311086","https://openalex.org/W1963580478","https://openalex.org/W1965154263","https://openalex.org/W1976334278","https://openalex.org/W2004783913","https://openalex.org/W2006419717","https://openalex.org/W2011692005","https://openalex.org/W2019716845","https://openalex.org/W2022320465","https://openalex.org/W2024709318","https://openalex.org/W2032306731","https://openalex.org/W2032359153","https://openalex.org/W2048397554","https://openalex.org/W2051808624","https://openalex.org/W2068341809","https://openalex.org/W2077442251","https://openalex.org/W2080194097","https://openalex.org/W2085360366","https://openalex.org/W2121612791","https://openalex.org/W2135886148","https://openalex.org/W2138603529","https://openalex.org/W2140606211","https://openalex.org/W2144406744","https://openalex.org/W2156593772","https://openalex.org/W2159011576","https://openalex.org/W2314919965","https://openalex.org/W2394995650","https://openalex.org/W2502993979","https://openalex.org/W2956630910","https://openalex.org/W2959792658","https://openalex.org/W3090293687","https://openalex.org/W4242925998"],"related_works":["https://openalex.org/W2729534900","https://openalex.org/W2032359153","https://openalex.org/W1271082088","https://openalex.org/W1972048366","https://openalex.org/W2133447633","https://openalex.org/W2080194097","https://openalex.org/W2020787068","https://openalex.org/W4232905219","https://openalex.org/W2598041141","https://openalex.org/W4412462431"],"abstract_inverted_index":{"AIMS:":[0],"Management":[1],"of":[2,29,102,110,158,185,238],"recent-onset":[3,36,242],"schizophrenia":[4,243],"(SZ)":[5],"and":[6,27,41,70,95,99,112,135,156,200,207,219,244],"schizoaffective":[7,245],"disorder":[8],"(SA)":[9],"is":[10],"challenging":[11],"owing":[12],"to":[13,17,23,52,75,85,128,190],"frequent":[14],"insufficient":[15],"response":[16,51],"antipsychotic":[18,86],"agents.":[19],"This":[20],"study":[21],"aimed":[22],"test":[24],"the":[25,30,93,100,125,236],"efficacy":[26],"safety":[28],"neurosteroid":[31],"pregnenolone":[32,78,131,159,181,225,234],"in":[33,153,241],"patients":[34,162,249],"with":[35,49,142,167,224,254],"SZ/SA.":[37],"METHODS:":[38],"Sixty":[39],"out-":[40],"inpatients":[42],"who":[43,163,250],"met":[44],"DSM-IV":[45],"criteria":[46],"for":[47,56],"SZ/SA,":[48],"suboptimal":[50],"antipsychotics":[53],"were":[54,73,92,164,209],"recruited":[55],"an":[57],"8-week,":[58],"double-blind,":[59],"randomized,":[60],"placebo-controlled,":[61],"two-center":[62],"add-on":[63,233],"trial,":[64],"that":[65],"was":[66,116,151,228],"conducted":[67],"between":[68],"2008":[69],"2011.":[71],"Participants":[72],"randomized":[74],"receive":[76],"either":[77],"(50":[79],"mg/day)":[80],"or":[81],"placebo":[82,191],"added":[83],"on":[84,196],"medications.":[87],"The":[88],"primary":[89],"outcome":[90],"measures":[91],"Positive":[94,134],"Negative":[96,103,136,186],"Symptoms":[97,104,137,187],"Scale":[98,138],"Assessment":[101,184],"scores.":[105,203],"Secondary":[106],"outcomes":[107],"included":[108],"assessments":[109],"functioning,":[111,206],"side-effects.":[113],"RESULTS:":[114],"Analysis":[115],"by":[117,213],"linear":[118],"mixed":[119],"model.":[120],"Fifty-two":[121],"participants":[122],"(86.7%)":[123],"completed":[124],"trial.":[126],"Compared":[127],"placebo,":[129],"adjunctive":[130,214],"significantly":[132,182,211],"reduced":[133,183],"negative":[139,239],"symptom":[140],"scores":[141,188],"moderate":[143],"effect":[144],"sizes":[145],"(d":[146,192],"=":[147,178,193],"0.79).":[148],"Significant":[149],"improvement":[150],"observed":[152],"weeks":[154],"6":[155],"8":[157],"therapy":[160],"among":[161,248],"not":[165,210,222,252],"treated":[166,253],"concomitant":[168,255],"mood":[169,175,256],"stabilizers":[170],"(arms":[171],"\u00d7":[172,174],"visit":[173],"stabilizers;":[176],"P":[177],"0.010).":[179],"Likewise,":[180],"compared":[189],"0.57),":[194],"especially":[195,247],"blunted":[197],"affect,":[198],"avolition":[199],"anhedonia":[201],"domain":[202],"Other":[204],"symptoms,":[205],"side-effects":[208],"affected":[212],"pregnenolone.":[215],"Antipsychotic":[216],"agents,":[217],"benzodiazepines":[218],"sex":[220],"did":[221],"associate":[223],"augmentation.":[226],"Pregnenolone":[227],"well":[229],"tolerated.":[230],"CONCLUSIONS:":[231],"Thus,":[232],"reduces":[235],"severity":[237],"symptoms":[240],"disorder,":[246],"are":[251,260],"stabilizers.":[257],"Further":[258],"studies":[259],"warranted.":[261]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1593774567","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
